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ABSTRACT: The interrelation of the processes of immunity and senescence now receives an unprecedented 
emphasis during the COVID-19 pandemic, which brings to the fore the critical need to combat immunosenescence 
and improve the immune function and resilience of older persons. Here we review the historical origins and the 
current state of the science of innate and adaptive immunity in aging and longevity. From the modern point of 
view, innate and adaptive immunity are not only affected by aging but also are important parts of its underlying 
mechanisms. Excessive levels or activity of antimicrobial peptides, C-reactive protein, complement system, 
TLR/NF-κB, cGAS/STING/IFN 1,3 and AGEs/RAGE pathways, myeloid cells and NLRP3 inflammasome, 
declined levels of NK cells in innate immunity, thymus involution and decreased amount of naive T-cells in 
adaptive immunity, are biomarkers of aging and predisposition factors for cellular senescence and aging-related 
pathologies. Long-living species, human centenarians, and women are characterized by less inflamm-aging and 
decelerated immunosenescence. Despite recent progress in understanding, the harmonious theory of 
immunosenescence is still developing. Geroprotectors targeting these mechanisms are just emerging and are 
comprehensively discussed in this article. 
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The interrelation of the processes of immunity and 
senescence now receives an unprecedented emphasis 
during the COVID-19 pandemic, which has stressed the 
critical need to combat immunosenescence and improve 
the immune function and resilience of older persons. At 
this time, it is appropriate to review the current state of the 
science of innate and adaptive immunity in aging and 
longevity, as well as the historical origins of this field of 
study, to further promote the research in this area. That is 
the subject of the present work.  
Historically, the field originated at the turn of the 
20th century with the work of Elie Metchnikoff whose 
175th anniversary we celebrated on May 15, 2020 (May 
15, 1845 – July 15, 1916). Metchnikoff is well recognized 
as a pioneering immunologist and microbiologist, a vice-
director of the Pasteur Institute in Paris, and the Nobel 
Laureate in Physiology or Medicine of 1908 for the 
discovery of phagocytosis (a major contribution to the 
cellular theory of immunity). Yet, he may also be well 
credited as “the father” of gerontology – the disciplinary 
term he coined. Both the terms “gerontology” (“the study 
of aging”) and “thanatology” (“the study of death”) were 
coined by him in the “Etudes On the Nature of Man” 
published in 1903, which may mark the beginning of these 
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scientific fields. Moreover, Metchnikoff can also be 
credited for the establishment of the interdisciplinary 
connection between these fields, in particular between 
aging research and immunology. Metchnikoff was the 
author of arguably the first systematic scientific theory of 
aging, interrelating the processes of immunity and 
senescence (www.longevityhistory.com/) [1]). In 
Metchnikoff’s own words: “We saw that, during aging, 
there occurs a struggle between noble elements 
(parenchymal tissues, e.g. the tissues of the muscle, 
kidney, lung, and brain) and phagocytes (“low/primitive 
elements”), and that the vitality of the former is, for the 
most part, diminished, whereas the latter, on the contrary, 
show increased activity. Therefore, it would seem that the 
means to use in the struggle against pathological aging 
should be, on the one hand, the strengthening of the most 
valuable elements of the organism, and on the other, the 
attenuation of the aggressive onslaught of the phagocytes. 
I must point out to the reader from the beginning that this 
problem is not yet solved, but its solution does not involve 
anything impossible. It is a scientific question, like many 
others.”  (Elie Metchnikoff, Etudy o Prirode Cheloveka 
(Etudes on the Nature of Man), The USSR Academy of 
Sciences Press, Moscow, 1961 (1903), Ch. X. “Vvedenie 
v nauchnoe izuchenie starosti” (An introduction to the 
scientific study of aging), pp. 201-202.) 
Following a century of study, at the present time, 
natural immunity is understood to consist of three 
interrelated parts: physiological barriers, innate immunity 
and adaptive immunity. All of these are affected by aging 
[2]. Immunosenescence results in increased susceptibility 
and severity of infectious diseases and non-communicable 
age-associated diseases, among them cancer, 
cardiovascular disease, and autoimmunity [3].  
The molecular mechanisms of the induction of 
inflammation and cellular senescence intersect through 
activation of the TLR/NF-κB, cGAS/STING/IFN 1,3, 
AGEs/RAGE molecular signaling pathways and the 
assembly of the NLRP3 inflammasome. Chronic sterile 
inflammation with aging was termed by Claudio 
Franceschi “inflamm-aging” [4]. The hyperactivation of 
the innate immunity response predominantly reduces the 
lifespan. 
Antimicrobial peptides are involved in chemotaxis 
and activation of innate and adaptive immunity cells in 
different animals from invertebrates to humans [5, 6]. On 
the model of Drosophila, it is shown that hyperactivation 
of different antimicrobial peptide genes significantly 
reduces the lifespan [7].  
Pathogen-associated molecular patterns of 
microorganisms are recognized by the innate immune 
system through inherited pattern-recognition receptors 
[8], including C-reactive protein [9], Toll-like-receptors 
[10] and some cytoplasmic receptors, including 
cGas/STING [11].  
 
 
Figure 1. Gut dysbiosis/permeability with aging can induce 
TLR in microglia and exerts mitochondrial dysfunction. 
 
C-reactive protein (CRP) is a soluble pathogen 
pattern recognition receptor. It binds to 1,6-
Bis(phosphocholine) of cell membranes of damaged cells 
or bacteria to induce complement or immune cell 
activation [9]. CRP hyperactivity is a biomarker of aging 
and is connected with inflammation and fibrosis [12].  
The complement system includes more than 50 
proteins in the plasma and cell membrane that act in 
response to activation of pattern recognition receptors, 
including CRP, killing microbes, sending danger signals, 
and accelerating apoptosis of damaged cells. There was 
established the participation of the complement system in 
the pathogenesis of aging-dependent diseases and their 
complications, including age-related macular 
degeneration [13] and type 2 diabetes [14]. 
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Toll-like receptors (TLR) cell surface receptors can 
recognize pathogen patterns from viruses, bacteria, or 
fungi to induce NF-kB proinflammatory signaling. TLR 
inhibition is a potential target to alleviate 
neuroinflammation [15]. TLR4 is of particular interest in 
connection with aging, since it can be activated by 
cytotoxic oxysterols (7-ketocholesterol), which are 
formed in tissues during inflammation or come from long-
stored food [16]. Its activation leads to mitochondrial 
dysfunction and an inflammatory reaction [17], including 
in brain microglia [18] (Fig. 1). TLR4 is inhibited by 
substances from cocoa [16]. Some polyphenols can 
suppress overexpression of inflammatory mediators 
through TLR4/NF-κB/STAT signaling intervention [19].  
 
 
 
Figure 2. AGEs/RAGE pathway and age-related diseases. 
cGas/STING pathway is the main intracellular 
sensor of viral invasion, including SARS-Cov-2, to 
induce Interferon 1 and 3 productions [20]. The STING 
pathway is also hyperactivated with aging by internal 
reasons, including retrotransposons, chromatin and 
mtDNA fragments in the cytosol with a consequent 
interferon induction, cellular senescence and apoptosis 
[21-24]. This could be a hypothetical reason for the 
greater severity of Covid-19 in elderly people. 
Some simple sugars (glucose, fructose) in the 
presence of transition metal ions (iron and copper) react 
chemically with amino acid residues (lysine, arginine) in 
proteins, such as collagen and elastin, causing the 
formation of glycation end products that not only increase 
the extracellular matrix stiffness, but also induce chronic 
inflammation through their RAGE receptors on the 
surface of cells (Fig. 2), such as vascular endothelium 
[25]. 
Cellular senescence itself can induce inflammation 
by secreting pro-inflammatory cytokines, the so-called 
Senescence Associated Secretory Phenotype (SASP) [26] 
(Fig. 3). 
According to Baker's study, elimination of senescent 
cells prolongs the lifespan and healthspan of mice [27, 
28]. 
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Figure 3. SASP involvement in aging-related pathologies. 
Adiposity is another source of inflamm-aging. 
Adipocyte hypertrophy leads to the secretion of 
proinflammatory leptin, lipocalin-2, progranulin, and 
chemoattractants for T- and B-cells [29-33] (Fig. 4). 
In addition, there are many other ways of induction 
of the main proinflammatory transcription factor NF-kB: 
overeating, obesity [34],  dysbiosis [35], psychological 
and chronic stress [36], vitamin D deficiency [37], 
circadian rhythm disturbance [38], aldosterone [39], 
angiotensin II [40], mitochondrial N-formyl peptides [41], 
oxidized mitochondrial DNA [42] (Fig. 5). 
In our experiments on the Drosophila model, we 
inhibited the different underlying pathways of NF-kB. In 
most cases, this led to an increase in lifespan [43-45]. 
It is worth noting that many substances of natural 
origin contained in food can inhibit NF-kB [46]. 
Aging is accompanied by gut microbiota alteration, 
like decreased overall diversity and an increased 
abundance of proinflammatory species, that can be a part 
of systemic inflammation and many aging-related 
diseases [47, 48]. 
Internal virome aging-related changes can affect 
different age-dependent diseases, including 
immunosenescence [49] and atherosclerosis [50] by 
cytomegalovirus, cancerogenesis by papillomaviruses 
[51] and Alzheimer’s by simple herpes [52-55]. 
 
 
 
 
 
 
Figure 4. The role of adiposity in inflammation. 
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Figure 5. Physiological stress factors can induce NF-kB 
pathway. 
 
 
Immune parameters associated with survival may 
vary in diverse populations of different ages. Therefore, 
we have to focus on the changes considered to be the 
hallmarks of immunosenescence, based on the literature 
data. The hallmarks of immunosenescence include: (i) a 
reduced ability to respond to new antigens; (ii) the 
accumulation of memory T cells; (iii) a lingering level of 
low-grade inflammation termed “inflamm-aging.” 
Mechanistically, immunosenescence is only partially 
explained by organismal and cellular senescence. 
Therefore, these hallmarks of immunosenescence would 
be markedly affected by the history of individual exposure 
to pathogens. In fact, several factors, such as genetics, 
nutrition, exercise, previous exposure to microorganisms, 
biological and cultural sex, and human cytomegalovirus 
(HCMV) status can influence immunosenescence [56]. 
Concerning sex/gender, in Western countries, 
women live 5-6 years more than men do. Furthermore, 
85% of over 100 years old are women. It is debated 
whether women live longer than men for reasons of 
gender or sex, e.g., for cultural or biological differences. 
However, females live longer than males in other animal 
species. There is sexual dimorphism in the immune 
response, i.e. females are more resistant to infections, but 
they have a higher incidence of autoimmune diseases 
compared to males, yet their relevance for life span is 
negligible. However, age-related changes in various 
immunological parameters differ between men and 
women.  Findings indicate that the slower rate of decline 
in immunological parameters in women than those in men 
is consistent with the fact that women live longer, than 
men do [57]. 
Concerning HCMV, virus status has a greater impact 
than age on the immune system because the virus 
contributes to shaping the immune profile and function 
during normal human aging. HCMV seropositivity is 
closely related to the reversal of the CD4/CD 8 T-cell 
ratio. In fact, persistent HCMV infection leads to chronic 
stimulation of CD8 T cells, which expand clonally 
showing an effector memory phenotype characterized by 
low CD28 expression. The absolute increase in memory 
T cells, called memory inflation, is observed only in older 
people infected by HCMV [58]. 
One of the pillars of adaptive immunity is the thymus. 
After an active period of creation and training of new T 
cells in childhood, at the time of puberty, the thymus 
undergoes involution, losing the stromal part and filling 
with fat [59], that can decrease T-cell repertoire to new 
antigens, including SARS-CoV-2. The involution is 
continuing during aging, because Wnt4 expression is 
down-regulated, while their Frizzled receptors and 
PPARgamma expression increases in the thymus [60]. On 
the contrary, peripheral T-cell numbers are maintained 
through the antigen-independent homeostatic 
proliferation of naive T cells that may lead to the 
emergence of dysfunctional memory-phenotype CD4+ T 
cell subpopulation (cell senescence-associated T cells, 
SA-T cells) [61]. SA-T cells secrete abundant pro-
inflammatory factors such as osteopontin and 
chemokines, playing a direct role in SASP [62].  
 
 
 
Figure 6. Thymus involution and inflamm-aging. 
 
CD8+ cytotoxic T lymphocytes [63] and NK cells 
[64] clear cells infected by viruses (e.g. SARS-CoV-2). 
However, CD8+ themselves undergo senescence [65]. 
Immunosenescence could be the reason for the 
dysfunction of immune clearance of senescent cells [66]. 
In addition, senescent cells avoid immune clearance 
through HLA-E-mediated inhibition of NK and CD8 + T 
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cells [67]. Thus, thymus involution is one of the 
mechanisms of inflamm-aging [68] (Fig. 6). 
Senescence of bone marrow hematopoietic stem cells 
is affected by (HSC) niche [69] and intrinsic factors [70], 
extracellular matrix stiffness [71], systemic inflammation 
[72] or other systemic factors [73]. With age, HSCs 
reduce the homing and regenerative capacity and increase 
proinflammatory myeloid-biased differentiation [74]. 
T follicular helper (TFH) cells are presented in 
lymphoid organs and in peripheral blood and help B cells 
for the production of immunoglobulins. Dysfunctional 
TFH cells with aging play a role in cancer, autoimmune 
and cardiovascular diseases [75]. 
Recent studies revealed that long-lived mammalian 
species are characterized by the particularities in their 
immune system. Cancer and other age-related disease-
resistant naked mole-rats lack canonical natural killer 
cells [76]. Many expanded gene families in the longest-
living microbat Myotis brandti are involved in the 
immune response [77]. Bats showed a unique, age-related 
pattern of gene expression associated with DNA repair, 
autophagy, immunity and tumor suppression, which can 
lead to an increase in their health span [78]. They also 
express a reduced inflammation response after viral 
infection [79]. The evaluation of the bowhead whale 
genome revealed the potentially relevant changes in genes 
related to the immune response [80].  
Human centenarians are a model for healthy aging. 
The longest living cohort of Italian centenarians has more 
favorable values of important immune parameters: naïve, 
activated/memory and effector/memory T cells [81]. 
Healthy centenarians presented with a distinct expression 
of proteins/pathways that reflect a healthy immune 
function, including less inflamm-aging and autoimmunity 
and increased B cell-mediated immune response [82].  
 
 
 
 
Figure 7. Changes occurring during aging (reproduced with permission from [56]). 
Centenarians have been used as an optimal model for 
successful aging. However, this model shows several 
limitations, in particular the selection of appropriate 
controls. Thus, the interest has been centered on 
centenarian offspring, since it is well known that they are 
healthier than the remaining old people are. Accordingly, 
significant differences between old subjects and 
centenarian offspring, in most of the studied T and B 
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subsets, show that centenarian offspring subsets present 
intermediate phenotyping between old and younger 
people. Therefore, centenarian offspring retain more 
youthful immunological parameters and the exhaustion of 
the immune system is less evident than in old people 
without centenarian parents [83]. Therefore, cell subset 
changes could represent a hallmark of successful or 
unsuccessful aging and could be used as a biomarker of 
human life span, potentially useful for the evaluation of 
immunosenescence treatment [83, 84]. 
Despite recent progress in understanding (Fig. 7), the 
harmonious theory of immunosenescence is still 
developing. 
Based on the present level of knowledge, the 
geroprotective therapies targeting the mechanisms of 
immunosenescence are just emerging [85]. Their studies 
need to intensify, with a broader identification of potential 
clinically applicable interventions and biomarkers, and 
their extensive pre-clinical and clinical testing [85].  
There are several hundreds of potential 
geroprotective interventions, that have been demonstrated 
on model organisms and collected in online databases 
Geroprotectors.Org [86] and DrugAge [87]. Not all of 
them meet the criteria of effective and safe treatment 
applicable for humans [88, 89].  
According to the clinical studies conducted around 
the world, exercise, fasting, caloric restriction, 
resveratrol, metformin and NAD precursors are the 
interventions with the highest number of clinical trials that 
target aging [90]. For all of them, a geroprotective effect 
on immunity is shown. Epidemiological data indicate that 
regular physical activity reduces the incidence of 
infectious diseases in the elderly, including viral and 
bacterial infections, as well as non-infectious diseases 
associated with the immune system, such as cancer and 
chronic inflammatory diseases [91]. Cyclic fasting 
decelerated the immunosuppression caused by 
chemotherapy and reversed age-dependent myeloid-bias 
in mice [92]. Cycles of fasting reduce autoimmunity and 
activate the lymphocyte-dependent killing of cancer cells 
in humans [93]. The immunological status of rodents 
under calorie restriction is superior to the immunological 
status of the non-restricted animals, involving activation 
of the upstream signaling molecules and cytokine gene 
expression that are altered with age [94].  
Arguably, there is no need to limit the entire diet. It is 
enough just to reduce the intake of certain nutrients to the 
necessary minimum. Protein restriction increased 
circulating interleukin-5 concentration in mice [95], that 
experimental overexpression in vivo significantly 
increases the number of eosinophils and B cells [96]. 
However, protein undernutrition is unfavorable for 
immune function in the elderly [97]. Methionine-deficient 
diet extends mouse lifespan and slows immune aging [98]. 
Branched-chain amino acid supplementation induced pro-
inflammatory gene expression in visceral adipose tissue 
in mice [95]. On the contrary, treatment by other animo 
acids may decrease the aging-related loss of immune 
system function. Thus, alanine supplementation has 
stimulated the proliferation of immune cells [99].  
Brian Kennedy et al. reviewed potential 
geroprotectors and paid special attention to rapamycin, 
senolytics, metformin, acarbose, spermidine, NAD+ 
enhancers and lithium [100]. Lithium presents a clear 
antiviral activity demonstrated at the preclinical level 
[101]. Lithium chloride confers protection against viral 
myocarditis via suppression of coxsackievirus B3 virus 
replication [102]. Lithium affects many aspects of 
immunity, including the activity of B- and T-cells, 
macrophages, interleukin-2 levels [103]. NAD precursors 
alleviate dysfunctional mitochondria in T cells [104]. 
Metformin enhances autophagy and normalizes 
mitochondrial function to alleviate aging-associated 
inflammation [105]. Acarbose benefits for immune 
function may be mediated by selective modulation of the 
gut microbiota [106]. After one year of treatment with 
acarbose or metformin, IL-6, TNF-α, IL-1β and ferritin 
levels of pro-inflammatory factors in type 2 diabetes 
patients were significantly decreased [107]. In accordance 
with a review [108], resveratrol can suppress the toll-like 
receptor and pro-inflammatory genes’ expression, 
associated with widespread health benefits for different 
autoimmune and chronic inflammatory diseases. 
Spermidine induces autophagy and improves the function 
of both the old mouse and old human B cells [109]. It has 
been proposed, that senolytics, i.e. drugs that selectively 
eliminate senescent cells that are the main source of pro-
inflammatory cytokines with aging, may prove to 
alleviate immune dysfunction in older individuals [110]. 
However, this assumption requires experimental 
confirmation. 
Rapamycin is a well-known potent immune-
suppressive agent in xenotransplantation [111]. 
Rapamycin caused reversible thymus involution in mice  
[112]. Nonetheless, in a randomized control trial in an 
older human cohort, rapamycin increased a myeloid cell 
subset and TREGS  [113]. Network-based transcriptomic 
drug repurposing for novel coronavirus 2019-
nCoV/SARS-CoV-2 revealed rapamycin along with 
melatonin and mercaptopurine as potential anti-HCoV 
drugs [114]. A large number of reports have documented 
a relationship between melatonin and the immune system 
[115]. 
Gaining this knowledge is urgently needed to enhance 
the quality of life and health span of the global aging 
population, to improve their resilience against both non-
communicable and communicable diseases. 
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